Hepatic encephalopathy in dogs
Abstract
Malfunctioning of the neutralizing function of the liver leads to the buildup of toxins in the body, which negatively impacts the central nervous system. The objective of our study was examining dogs that had typical concurrent symptoms of dysfunctions of the liver and central nervous system. We studied two groups of dogs – the control (clinically healthy) and experimental (sick dogs with symptoms of disorders of the liver and brain). Each of the groups consisted of 10 animals: four Yorkshire Terriers, two Maltese dogs, two Russian Toy dogs, one English Cocker Spaniel, and one mixed-breed dog. The animals were examined clinically, underwent ultrasound diagnostics, and had their blood collected for labororary analyses. Clinically, in all the sick dogs, we identified the typical symptoms of liver lesions – pain in the liver region, increase in its area, and also malfunctioning of the central nervous system manifesting in soporous state, ataxis, and spasms. In blood plasma of all the sick dogs, we observed significant increase in the concentration of ammonia. High ammonia content in blood of dogs indicates an impaired neutralizing function of the liver. At the same time, it is the main endotoxin that affects the central nervous system, promoting the development of liver encephalopathy. The level of hyperammonemia was closely associated with the severity of the course of pathology. In blood serum of the dogs with signs of liver encephalopathy, the content of bile acids increased 4.5-fold and total bilirubin increased 31%, while albumin decreased 15%. In the blood of 60% of the patients, the level of Na+ was low. In serum of blood from the patients, the activities of AST, ALT, and AP were increased. The ultrasound studies of the liver revealed increased echostructure and impaired hemodynamics, which, when co-occurring with high activity of indicator enzymes, indicate damage to liver cells. During severe liver encephalopathy, the dogs were found to have leukocytosis, neutrophilia, and lymphocytopenia, and also decline in the content of hemoglobin, number of erythrocytes, and hematocrit value. The next stage of our research will focus on the role of portosystemic shunts in the development of hepatic encephalopathy in dogs.References
Alvarez, L., & Whittemore, J. (2009). Liver enzyme elevations in dogs: Diagnostic approach. Compendium: Continuing Education for Veterinarians, 31(9), 416–418.
Assawarachan, S. N., Chuchalermporn, P., Maneesaay, P., & Thengchaisri, N. (2019). Evaluation of hepatobiliary ultrasound scores in healthy dogs and dogs with liver diseases. Veterinary World, 12(8), 1266–1272.
Assawarachan, S. N., Maneesaay, P., & Thengchaisri, N. A. (2020). Descriptive study of the histopathologic and biochemical liver test abnormalities in dogs with liver disease in Thailand. Canadian Journal of Veterinary Research, 84(3), 217–224.
Assawarachan, S. N., Ongvisespaibool, T., Hakhen, B., Chuchalermporn, P., Maneesaay, P., & Thengchaisri, N. (2023). Predictive factors for two-year survival in dogs with hepatobiliary diseases: Importance of clinical and laboratory monitoring. Animals, 13(16), 2677.
Bellafante, D., Gioia, S., Faccioli, J., Riggio, O., Ridola, L., & Nardelli, S. (2024). The management of hepatic encephalopathy from ward to domiciliary care: Current evidence and gray areas. Journal of Clinical Medicine, 13(1), 166.
Besa, C., Cruz, J. P., Huete, A., & Cruz, F. (2012). Portal biliopathy: A multitechnique imaging approach. Abdominal Imaging, 37, 83–90.
Caporali, E. H. G., Phillips, H., Underwood, L., & Selmic, L. E. (2015). Risk factors for urolithiasis in dogs with congenital extrahepatic portosystemic shunts: 95 cases (1999–2013). Journal of the American Veterinary Medical Association, 246, 530–536.
Chapman, S. E., & Hostutler, R. A. (2013). A laboratory diagnostic approach to hepatobiliary disease in small animals. Veterinary Clinics of North America: Small Animal Practice, 43, 1209–1225.
Cheon, S. Y., Jo, D., Kim, Y. K., & Song, J. (2022). Long noncoding RNAs regulate hyperammonemia-induced neuronal damage in hepatic encephalopathy. Oxidative Medicine and Cellular Longevity, 2022, 7628522.
Elhiblu, M. A., Dua, K., Mohindroo, J., Mahajan, S. K., Sood, N. K., & Dhaliwal, P. S. (2015). Clinico-hemato-biochemical profile of dogs with liver cirrhosis. Veterinary World, 8, 487–491.
European Association for the Study of the Liver (2022). EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. Journal of Hepatology, 77(3), 807–824.
Farhoodimoghadam, M., Reagan, K. L., & Zwingenberger, A. L. (2024). Diagnosis and classification of portosystemic shunts: A machine learning retrospective case-control study. Frontiers in Veterinary Science, 11, 1291318.
Ferenci, P. (2017). Hepatic encephalopathy. Gastroenterology Report, 5(2), 138–147.
Gluud, L. L., Vilstrup, H., & Morgan, M. Y. (2016). Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis. Hepatology, 64, 908–922.
Gow, A. G. (2017). Hepatic encephalopathy. Veterinary Clinics of North America: Small Animal Practice, 47(3), 585–599.
Hadjihambi, A., Harrison, I. F., Costas-Rodríguez, M., Vanhaecke, F., Arias, N., Gallego-Durán, R., Mastitskaya, S., Hosford, P. S., Olde Damink, S. W. M., Davies, N., Habtesion, A., Lythgoe, M. F., Gourine, A. V., & Jalan, R. (2019). Impaired brain glymphatic flow in experimental hepatic encephalopathy. Journal of Hepatology, 70(1), 40–49.
Jalan, R., Shawcross, D., & Davies, N. (2003). The molecular pathogenesis of hepatic encephalopathy. The International Journal of Biochemistry and Cell Biology, 35(8), 1175–1181.
Jawaro, T., Yang, A., Dixit, D., & Bridgeman, M. B. (2016). Management of hepatic encephalopathy: A primer. Annals of Pharmacotherapy, 50(7), 569–577.
Kabaria, S., Dalal, I., Gupta, K., Bhurwal, A., Minacapelli, C. D., Catalano, C., & Rustgi, V. (2021). Hepatic encephalopathy. Hepatology, 9(1), 89–97.
Kashliak, N. O., & Vlizlo, V. V. (2023). Symptomy, biokhimichni pokaznyky ta zahal’nyj analiz krovi za hepatopatiji u sobak [Symptoms, biochemical indicators and general blood analysis for hepatopathy in dogs]. Scientific Messenger of Lviv National University of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences, 112, 193–200 (in Ukrainian).
Kawaguchi, T., Suzuki, F., Imamura, M., Murashima, N., Yanase, M., Mine, T., Fujisawa, M., Sato, I., Yoshiji, H., Okita, K., & Suzuki, K. (2019). Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials. Hepatology Research, 49(4), 404–418.
Kilpatrick, S., Gow, A. G., Foale, R. D., Tappin, S. W., Carruthers, H., Reed, N., Yool, D. A., Woods, S., Marques, A. I., Jalan, R., Mellanby, R. J. (2014). Plasma cytokine concentrations in dogs with a congenital portosystemic shunt. The Veterinary Journal, 200(1), 197–199.
Konstantinidis, A. O., Patsikas, M. N., Papazoglou, L. G., & Adamama-Moraitou, K. K. (2023). Congenital portosystemic shunts in dogs and cats: Classification, pathophysiology, clinical presentation and diagnosis. Veterinary Sciences, 10(2), 160.
Kraun, M. B., Nelson, L. L., Hauptman, J. G., & Nelson, N. C. (2014). Analysis of the relationship of extrahepatic portosystemic shunt morphology with clinical variables in dogs: 53 cases (2009–2012). Journal of the American Veterinary Medical Association, 245(5), 540–549.
Krishnarao, A., & Gordon, F. D. (2020). Prognosis of hepatic encephalopathy. Clinics in Liver Disease, 24(2), 219–229.
Lawrence, Y. A., & Steiner, J. M. (2017). Laboratory evaluation of the liver. Veterinary Clinics of North America: Small Animal Practice, 47, 539–553.
Lester, C., Cooper, J., Peters, R. M., & Webster, C. R. L. (2016). Retrospective evaluation of acute liver failure in dogs (1995–2012): 49 cases. Veterinary Emergency and Critical Care Society, 26(4), 559–567.
Levitt, D. G., & Levitt, M. D. (2018). A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans. Clinical and Experimental Gastroenterology, 11, 193–215.
Lidbury, J. A., Cook, A. K., & Steiner, J. M. (2016). Hepatic encephalopathy in dogs and cats. Veterinary Emergency and Critical Care Society, 26(4), 471–487.
Lidbury, J. A., Ivanek, R., Suchodolski, J. S., & Steiner, J. M. (2015). Putative precipitating factors for hepatic encephalopathy in dogs: 118 cases (1991–2014). Journal of the American Veterinary Medical Association, 247(2), 176–183.
Lima, L. C. D., Miranda, A. S., Ferreira, R. N., Rachid, M. A., & Simões e Silva, A. C. (2019). Hepatic encephalopathy: Lessons from preclinical studies. World Journal of Hepatology, 11(2), 173–185.
Lynch, A. (2023). Hepatic encephalopathy. Small Animal Critical Care Medicine, 506–509.
Mullins, R. A., Carrera, A. E., Anderson, D. M., & Billet, J.-P. (2022). Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review. Veterinary Surgery, 51(1), 23–33.
Nardelli, S., Bellafante, D., Ridola, L., Faccioli, J., Riggio, O., & Gioia, S. (2023). Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate. Metabolic Brain Disease, 38(5), 1729–1736.
Odeh, M. (2007). Pathogenesis of hepatic encephalopathy: The tumour necrosis factor-alpha theory. European Journal of Clinical Investigation, 37(4), 291–304.
Romero-Gómez, M., Montagnese, S., & Jalan, R. (2015). Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Journal of Hepatology, 62(2), 437–447.
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020). Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. Journal of Hepatology, 73(6), 1526–1547.
Rothuizen, J. (2009). Important clinical syndromes associated with liver disease. Veterinary Clinics of North America: Small Animal Practice, 39(3), 419–437.
Selgas, A. G., Bexfield, N., Scase, T. J., Holmes, M. A., & Watson, P. (2014). Total serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis. Journal of Veterinary Diagnostic Investigation, 26(2), 246–251.
Seller, S., Weisse, C., & Fischetti, A. J. (2022). Intrahepatic venous collaterals in dogs with congenital intrahepatic portosystemic shunts are associated with focal shunt or hepatic vein narrowing. Veterinary Radiology and Ultrasound, 63(1), 64–72.
Simonov, M., & Vlizlo, V. (2015). Some blood markers of the functional state of liver in dairy cows with clinical ketosis. Bulgarian Journal of Veterinary Medicine, 18(1). 74–82.
Swaminathan, M., Ellul, M. A., & Cross, T. J. (2018). Hepatic encephalopathy: Current challenges and future prospects. Hepatic Medicine: Evidence and Research, 10, 1–11.
Tivers, M. S., Handel, I., Gow, A. G., Lipscomb, V. J., Jalan, R., & Mellanby, R. J. (2014). Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One, 9(1), e82303.
Vallarino, N., Pil, S., Devriendt, N., Or, M., Vandermeulen, E., Serrano, G., Paepe, D., Bosmans, T., & de Rooster, H. (2020). Diagnostic value of blood variables following attenuation of congenital extrahepatic portosystemic shunt in dogs. Veterinary Record, 187(7), e48.
Vlizlo, V. V. (1999). Hepatozerebralnyj syndrom u velykoyi rohatoyi khudoby [Hepatocerebral syndrome in cattle]. Visnyk Ahrarnoyi Nauky, 8, 29–33 (in Ukrainian).
Vlizlo, V., Prystupa, O., Slivinska, L., Gutyj, B., Maksymovych, I., Shcherbatyy, A., Lychuk, M., Partyka, U., Chernushkin, B., Rusyn, V., Leno, M., & Leskiv, K. (2023). Treatment of animals with fatty liver disease using a drug based on the seeds of Silybum marianum. Regulatory Mechanisms in Biosystems, 14(3), 424–431.
Wang, A. J., Peng, A. P., Li, B. M., Gan, N., Pei, L., Zheng, X. L., Hong, J. B., Xiao, H. Y., Zhong, J. W., & Zhu, X. (2017). Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World Journal of Gastroenterology, 23(34), 6321–6329.
Webster, C. R. L. (2017). Hemostatic disorders associated with hepatobiliary disease. Veterinary Clinics of North America: Small Animal Practice, 47, 601–615.
Webster, C. R. L., Center, S. A., Cullen, J. M., Penninck, D. G., Richter, K. P., Twedt, D. C., & Watson, P. J. (2019). ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. Journal of Veterinary Internal Medicine, 33(3), 1173–1200.
Xenoulis, P. G., & Steiner, J. M. (2015). Canine hyperlipidaemia. Journal of Small Animal Practice, 56(10), 595–605.
Zelenina, O., Vlizlo, V., Kozak, M., Ostapiv, D., Samaryk, V., Dron, I., Stetsko, T., Skrypka, M., Tomchuk, V., Danchuk, O., & Levchenko, A. (2022). Antimicrobial activity of the PEGylated antibiotic enrofloxacin and its functional and structural effect on the liver in rats. Journal of Applied Pharmaceutical Science, 12(6), 68–75.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
